AFLAC INC 10-Q Summary: Quarter Ended March 31, 2003
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2003, for AFLAC Incorporated and its subsidiaries. The company operates primarily in two segments: AFLAC Japan and AFLAC U.S., providing supplemental health and life insurance. The financial statements are unaudited but have been reviewed by independent auditors KPMG LLP. The company reported 513,370,656 shares of common stock outstanding as of May 6, 2003.
Key Financial Metrics
| Metric (in millions) | Q1 2003 | Q1 2002 |
|---|---|---|
| Total Revenues | $2,807 | $2,371 |
| Premiums | $2,372 | $1,998 |
| Net Investment Income | $430 | $381 |
| Net Earnings | $237 | $183 |
| Operating Earnings (Non-GAAP) | $244 | $192 |
| Diluted EPS (GAAP) | $0.45 | $0.34 |
| Diluted EPS (Operating) | $0.46 | $0.36 |
| Total Assets | $45,341 | $45,058 |
| Total Liabilities | $38,329 | $38,664 |
| Shareholders' Equity | $7,012 | $6,394 |
| Cash and Cash Equivalents | $985 | $523 |
| Notes Payable | $1,311 | $1,312 |
Cash Flow: Net cash provided by operating activities was $975 million. Net cash used by investing activities was $1,322 million, primarily for purchasing debt securities. Net cash used by financing activities was $51 million, driven by share repurchases ($53 million) and dividends ($34 million).
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 18.4% year-over-year, driven by an 18.7% increase in premiums and a 12.8% increase in net investment income.
- Earnings Growth: Net earnings rose 29.9% to $237 million. Operating earnings (excluding realized investment gains/losses and currency swap impacts) increased 26.8% to $244 million.
- Segment Performance:
- AFLAC Japan: Pretax operating earnings grew 29.3% to $285 million. Premium income increased 18.6% to $1,748 million. Sales of new annualized premiums rose 12.1% in yen terms, driven by the "EVER" medical policy and "Rider MAX" conversions.
- AFLAC U.S.: Pretax operating earnings grew 15.5% to $107 million. Premium income increased 19.0% to $624 million. New annualized premium sales rose 8.8% to $256 million.
- Foreign Currency Impact: The yen strengthened 11.6% against the dollar (weighted average 118.93 vs. 132.69). This translation effect increased reported operating earnings by approximately $0.02 per diluted share. Excluding currency fluctuations, operating earnings per share increased 22.2%.
- Investment Portfolio: Net unrealized gains on investment securities increased to $2.87 billion (net of tax) from $2.42 billion. The company reclassified two issuers from held-to-maturity to available-for-sale due to credit rating downgrades.
Guidance, Outlook, and Risks
- 2003 Guidance: Management targets a 15% to 17% increase in operating earnings per diluted share, excluding the impact of currency translation. The specific objective is to achieve at least $1.80 in operating EPS excluding currency effects.
- AFLAC Japan Sales: Targeting 5% to 10% growth in new annualized premium sales in yen terms.
- AFLAC U.S. Sales: Revised expectation for 10% to 15% growth in new annualized premium sales for the year (down from a previous 15% target due to first-quarter results and organizational changes).
- Market Risks:
- Currency Risk: Significant exposure to yen/dollar fluctuations. A weaker yen reduces reported dollar earnings. The company uses cross-currency swaps and yen-denominated debt to hedge this exposure.
- Interest Rate Risk: A 100 basis point increase in interest rates is estimated to reduce the fair value of debt securities by $3.7 billion. The company faces reinvestment risk in Japan due to low yields on yen-denominated securities.
- Contingencies: The company is a defendant in various lawsuits but believes outcomes will not have a material adverse effect. There is a commitment to purchase leased land in Japan with a fair value of approximately $15 million.
- Capital Actions: The company repurchased approximately 2 million shares in Q1 2003. Approximately 15 million shares remain available under the repurchase program. The quarterly dividend was increased to $0.07 per share.
Investor Verification Checklist
- Currency Sensitivity: Verify the impact of the yen/dollar exchange rate on future earnings, as a significant portion of profits originates in Japan.
- Investment Yield Spread: Monitor the spread between investment yields and required interest rates on policy reserves, particularly in the Japanese market where yields have declined.
- Product Mix Shift: Confirm the sustainability of sales growth driven by new products (EVER, Rider MAX) versus traditional cancer life policies.
- Credit Quality: Review the composition of below-investment-grade holdings (4.1% of total debt securities at amortized cost) and split-rated securities.
- Regulatory Capital: Assess the impact of new Japanese statutory accounting standards on solvency margin ratios and profit repatriation capabilities.